Drug discovery focused on novel pathogenic proteins for pulmonary arterial hypertension

•Pulmonary arterial hypertension (PAH) is a fatal disease.•Early diagnosis of PAH is difficult because there is no biomarker.•Prognosis will be improved through the development of an early diagnostic technique.•We are now proceeding with drug discovery and biomarker development.